Completed Screenings
This page lists those policies from the Region Wide Screening and EQIA programme which have undergone screening from 1st April 2008 - 31st March 2009 and the outcome of that screening.
Policy | Date | Decision |
|---|---|---|
Development of a strategy for technological innovation in health and social care services | Completed Feb 09 | No EQIA |
The Travelling Expenses and Remission of Charges (Amendment No.3) Regulations (Northern Ireland) 2008 | Completed August 08 | No EQIA |
The Travelling Expenses and Remission of Charges (Amendment No.4) Regulations (Northern Ireland) 2008 | Completed Dec 08 | No EQIA |
The General Ophthalmic Services (Amendment No. 2) Regulations (Northern Ireland) 2009. | Completed July 08 | No EQIA |
The Travelling Expenses and Remission of Charges (Amendment No. 2) Regulations (Northern Ireland) 2009 | Completed March 09 | No EQIA |
Northern Ireland Interim Contingency Plan for Health Response for an Influenza Pandemic | Completed March 09 | No EQIA |
Hidden Harm Action Plan | Completed July 08 | No EQIA |
Human Papillomavirus Immunisation | Completed Aug 08 | No EQIA |
The Medicines (Products for Human Uses) (Fees) Regulations 2009 | Completed Feb 09 | No EQIA |
Code of Practice on Protecting Confidentiality of Service User Information | Completed Oct 08 | No EQIA |
Autism Spectrum Disorder (ASD) Strategic Action Plan 2008/09 – 2010/11 | Completed April 08 | No EQIA |
The introduction of principles into mental health and mental capacity legislation. | Completed June 08 | No EQIA |
Guidance on The Assessment and Management of Risk in Adult Mental Health Services | Completed July 08 | No EQIA |
Government response to Bamford independent review of mental health and learning disability policy, services and legislation. | Completed April 08 | No EQIA |
Regional Business Services Organisation - Interim Headquarters Location. | Completed Jan 09 | No EQIA |
Location of the Headquarters for the Regional Health and Social Care Board (RHSCB) and the Regional Agency for Public Health and Social Wellbeing (Agency). | Completed Jan 09 | No EQIA |
Location of the Headquarters and local offices for the Patient Client Council. | Completed Jan 09 | No EQIA |
Ministerial decision that in future all HSC bodies should seek legal advice from the Directorate of Legal Services. | Completed Sept 2008 | No EQIA |
The Charges for Drugs and Appliances (Amendment) Regulations (Northern Ireland) 2008 | Completed June 2008 | No EQIA |
The Primary Medical Services Performers List System | Completed October 08 | No EQIA |
Consultation on the draft Fire Safety Regulations (Northern Ireland) 2009 | Completed October 08 | No EQIA |
Service Development Framework: Respiratory health and wellbeing | Completed August 08 | No EQIA |
Improving Stroke Services | Completed May 08 | No EQIA |
Bereavement Strategy | Completed Nov 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) clinical guideline on Osteoarthritis | Completed April 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) clinical guideline on Prostate Cancer | Completed April 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Substance Misuse among vulnerable young | Complete June 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Prophylaxis against Infective Endocarditis | Completed July 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Adalimumab for the Treatment of Psoriasis | Completed July 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Cetuximab for the Treatment of Head & Neck Cancer | Completed July 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Abatacept for the Treatment of Rheumatoid Arthritis | Completed July 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Colitis (ulcerative) - Infliximab | Completed July 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) technology appraisal – Infliximab for subacute manifestations of ulcerative colitis | Completed Apr 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) technology appraisal – Erythropoetin (alpha and beta) and darbepoetin for the treatment of cancer-treatment induced anaemia | Completed Apr 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) technology appraisal – Adalimumab, Etanercept and Infliximab for Ankylosing Spondylitis | Completed Apr 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) technology appraisal - Structural Neuroimaging for Atypical Psychosis | Completed Apr 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Pegaptanib and Ranibizumab for the Treatment of Age-related Macular Degeneration | Completed Sept 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) public health guidance on Smoking Cessation Services. | Completed June 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline Respiratory Tract Infections | Completed Oct 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline Familail Hypercholesterolaemia | Completed Oct 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline Induction of Labour | Completed Oct 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline Stroke | Completed Oct 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal Amantadine, Oseltamivir and Zanamivir for Influenza Prophylaxis | Completed Oct 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal Telbivudine for the Treatment of Hepatitis B | Completed Oct 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal Entecavir for the Treatment of Hepatitis B | Completed Oct 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal Infliximab for the Treatment of Subactute Manifestations of Ulcerative Colitis | Completed Oct 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Routine Antenatal Anti-D Prophylaxis for Women who are Rhesus D Negative | Completed Sept 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Public Health Guidance - Promoting Physical Activity in the Workplace | Completed Sept 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Public Health Guidance – Preventing the Uptake of Smoking by Children and Young People | Completed Sept 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline - Irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care | Completed Jan 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline Management of Iinadvertent perioperative hypothermia in adults | Completed Jan 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline Diabetes – type 2 (update) | Completed Jan 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline Lipid Modification | Completed Jan 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Corticosteroids for the Treatment of Chronic Asthma in adults and children aged 12 years and over. | Completed Jan 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Public Health Guidance – Identifying and Supporting Those Most at Risk of Dyeing Prematurely | Completed Jan 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Public Health Guidance – Mental wellbeing and Older People | Completed Jan 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Diabetes Insulin Pump Therapy | Completed Jan 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal –Coronary Artery Disease Drug Eluting stents | Completed Jan 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal –Venous Thromboeembolism – Dabigatran | Completed Jan 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal –Osteoporosis Primary Prevention | Completed Jan 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Osteoporosis Secondary Primary Prevention | Completed Jan 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Cancer Services l Guideline – Improving Outcomes for people with Skin Tumours including melanoma | Completed Feb 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline - Metastatic spinal cord compression: diagnosis and management of adults at risk of and with metastatic spinal cord compression | Completed Feb 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology - Machine perfusion systems and cold static storage of kidneys from deceased donors | Completed Feb 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Borderline Personality Disorder. | Completed March 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Antisocial Personality Disorder | Completed March 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Medicines Adherence | Completed March 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Sunitinib for Renal Cell Carcinoma | Completed March 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Chronic Kidney Disease | Completed Feb 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Surgical Site Infection | Completed Feb 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Attention Deficit Hyperactivity Disorder | Completed Feb 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Erlotinib for the Treatment of Non-small Cell Lung Cancer | Completed Feb 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Spinal Cord Stimulation for Chronic Pain of Neuropathic or Ischaemic Origin | Completed Feb 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Hearing Impairment – cochlear implants for severe to profound deafness in children and adults | Completed March 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Amantadine, oseltamivir and zanamivir for the treatment of influenza (review of existing guidance No58) | Completed March 09 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) public health guidance on School-based Interventions on Alcohol. | Completed June 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) public health guidance on Social and Emotional Wellbeing in Primary Education | Completed June 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) public health guidance on Physical Activity and the Environment | Completed June 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) public health guidance on Maternal and Child Nutrition | Completed June 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) – Irritable Bowel Syndrome | Completed April 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE)– Surgical Management of Otitis Media with Effusion in Children U-12 | Completed April 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE)– Prophylaxis Against Inefective Endocarditis | Completed April 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE)– Antenatal Care | Completed April 08 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE)– Diabetes in Pregnancy | Completed April 08 | No EQIA |
